EUVIMEDEUVIMED entdecken
Crossref

CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors

Ingo Hartlapp, Philipp E Hartrampf, Sebastian E Serfling, Vanessa Wild, Alexander Weich, Leo Rasche, Sabine Roth, Andreas Rosenwald, Patrick W Mihatsch, Anne Hendricks, Armin Wiegering, Verena Wiegering und 9 weitere

Journal of Nuclear Medicine · 2023

DOI: 10.2967/jnumed.123.265464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Ingo Hartlapp und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Desmoplastic Small Round Cell Tumor, Coordination Complexes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Desmoplastic small round cell tumor (DSRCT) is a rare, radiosensitive, yet difficult-to-treat sarcoma subtype affecting predominantly male adolescents. Extensive intraperitoneal seeding is common and requires multimodal management. With no standard therapy established, the prognosis remains poor, and new treatment options are needed. We demonstrate the clinical potential of C-X-C motif chemokine receptor 4 (CXCR4)-directed imaging and endoradiotherapy in DSRCT.

Methods

Eight male patients underwent dual-tracer imaging with [18F]FDG and CXCR4-directed [68Ga]pentixafor PET/CT. A visual comparison of both tracers, along with uptake quantification in active DSRCT lesions, was performed. [68Ga]pentixafor uptake was correlated with immunohistochemical CXCR4 expression on tumor cells. Four patients with end-stage progressive disease underwent CXCR4-based endoradiotherapy. We report the safety, response by RECIST 1.1, and survival after endoradiotherapy.

Results

Uptake of [68Ga]pentixafor in tumor lesions was demonstrated in all patients with DSRCT, providing diagnostic power comparable to [18F]FDG PET. Corresponding CXCR4 expression was confirmed by immunohistochemistry in all DSRCT biopsies. Finally, 4 patients were treated with CXCR4-directed [90Y]endoradiotherapy, 3 in a myeloablative dose range with subsequent autologous stem cell transplantation. All 3 required transfusions, and febrile neutropenia occurred in 2 patients (resulting in 1 death). Notably, severe nonhematologic adverse events were absent. We observed signs of response in all 3 patients, translating into disease stabilization in 2 patients for 143 and 176 d, respectively. In the third patient, postmortem autopsy confirmed a partial pathologic response.

Conclusion

We validated CXCR4 as a diagnostic biomarker and a promising target for endoradiotherapy in DSRCT, demonstrated its feasibility, and provided the first evidence of its clinical efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationDesmoplastic Small Round Cell TumorCoordination ComplexesAdolescentHumansMaleFemalePositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Gallium RadioisotopesTransplantation, AutologousPeptides, CyclicReceptors, CXCR4

Stichwörter der Autor:innen

CXCR4desmoplastic small round cell tumorendoradiotherapytheranostics

Substanzen

Fluorodeoxyglucose F18Gallium RadioisotopesPeptides, CyclicCoordination ComplexesReceptors, CXCR4CXCR4 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
  • Department of Nuclear Medicine and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
  • Department of Pathology and Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
  • Department of Diagnostic and Interventional Radiology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
  • Department of General, Visceral, Transplantation, Vascular, and Pediatric Surgery and Comprehensive Cancer Center Mainfranken Würzburg, University Hospital Würzburg, Würzburg, Germany.
  • Children's Hospital and Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.

Zitieren

APA

Hartlapp, I., Hartrampf, P. E., Serfling, S. E., Wild, V., Weich, A., Rasche, L., Roth, S., Rosenwald, A., Mihatsch, P. W., Hendricks, A., Wiegering, A., Wiegering, V., Hänscheid, H., Schirbel, A., Werner, R. A., Buck, A. K., Wester, H. J., Einsele, H., Kunzmann, V., …, & Kortüm, K. M. (2023). CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.265464

Vancouver

Hartlapp I, Hartrampf PE, Serfling SE, Wild V, Weich A, Rasche L, et al. CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.123.265464

BibTeX
@article{Hartlapp2023,
  author = {Hartlapp, Ingo and Hartrampf, Philipp E and Serfling, Sebastian E and Wild, Vanessa and Weich, Alexander and Rasche, Leo and Roth, Sabine and Rosenwald, Andreas and Mihatsch, Patrick W and Hendricks, Anne and Wiegering, Armin and Wiegering, Verena and Hänscheid, Heribert and Schirbel, Andreas and Werner, Rudolf A and Buck, Andreas K and Wester, Hans-Jürgen and Einsele, Hermann and Kunzmann, Volker and Lapa, Constantin and Kortüm, K Martin},
  title = {CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  doi = {10.2967/jnumed.123.265464}
}
Kostenlos starten →